Bipolar Disorder (BD)FOCUS BipolarNCT07622927
FOCUS Bipolar: Families Opening Conversations for Understanding Signs
An observational study of Bipolar Disorder (BD) and Bipolar Disorder I or II, run by University of Texas Southwestern Medical Center at 1 site in United States.
Trial summary
Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder. Read more about this study
- Who is it for?
- Ages 7 years and olderHealthy volunteers can take part
- Conditions the study is for
- Bipolar Disorder (BD), Bipolar Disorder I or II, Bipolar Disorder Family Members
- What is being tested?
- Co-design Workshop (Observational Procedure), Alpha Testing (Observational Procedure) and Beta Testing (Observational Procedure)
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- 11 Mar 2026to 31 Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The following groups are being targeted for this observational study: 1. Parents (age 18 or older) who have ever been diagnosed with bipolar disorder and have a biological child between the ages of 7-21 2. Caregivers (age 18 or older) who are primarily responsible for a child between the ages of 7-21 whose biological parent has a lifetime diagnosis of bipolar disorder 3. Youth (ages 7-21) without bipolar disorder, but has at least 1 biological parent with a lifetime diagnosis of bipolar disorder
Who may be able to join
- Age: 18 years or older.
- Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder.
- Capacity and willingness to consent: Able and willing to provide informed consent.
- Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
- Language: Able to read, speak, and understand English.
- Age:
Show all 21Show fewer
- Phase 1 (co-design) and Phase 2A (alpha testing): 13-18 years
- Phase 2B (beta testing): 13-18 years
- Phase 3 (screening): 7-21 years
- Diagnosis status: Must not have a current diagnosis of Bipolar I or II disorder.
- Parental diagnosis: Has at least 1 biological parent with a lifetime, clinician-confirmed Bipolar I or II diagnosis (as defined in Groups A and B).
- Consent/Assent:
- For youth aged 18-21: Able and willing to provide informed consent (verbal)
- For youth aged 7-21: Parent/guardian/LAR able and willing to provide informed consent (verbal) and youth able to provide assent (verbal)
- Participant ability: Able and willing to participate in study activities (e.g., co-design discussions, questionnaires, or screening assessments.
- Language: English sufficient to comprehend study procedures and materials.
- Criteria for Exclusion of Participants
- A potential participant will NOT be eligible for participation in this study if any of the following criteria are met:
- Unable to provide informed consent due to cognitive impairment or language barriers
- Experiencing acute psychiatric instability at enrollment (e.g., acute psychosis or acute suicidality without stabilization)
- Has a medical or psychiatric condition that, in the judgment of the Principal Investigator or study clinician, would place undue risk on the individual or interfere with standard clinical care
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
UT Southwestern Medical Center
Dallas, Texas, 75390
Karabi Nandy, Ph.D., 214-648-9551, FOCUSBipolar@UTSouthwestern.edu
About this study
Official title: A Data-Driven Approach to Early Mental Health Screening in Offspring of Parents With Bipolar Disorder
Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder.
The main questions addressed by this project are:
Read more
Whether a co-designed video decision aid improves caregiver understanding of bipolar disorder genetic risk and supports informed decisions about youth screening.
Whether remote mental health screening tools are feasible and acceptable for youth with familial risk for bipolar disorder.
Whether screening results can be used to identify early risk patterns and inform tailored follow-up recommendations.
Participants may be involved in one or more study activities, including co-design of educational decision-aid content, feedback on decision-aid prototypes, beta testing of the decision aid, and remote youth mental health screening. The study does not assign treatment and does not change existing clinical care or clinic routines.
Read the detailed description
Background and Rationale:
Bipolar disorder (BD), characterized by acute mood fluctuations between manic and depressive states, affects approximately 5.7 million adults each year in the United States and is the fourth leading cause of disability among those aged 10-24 worldwide. BD is estimated to inflict an annual economic burden of $195 billion in the United States alone. Despite its high prevalence and significant impact on both disability and the economy, BD is typically diagnosed 11-17 years after symptom emergence. This results in delayed intervention, increased morbidity, and an elevated suicide risk.
While the etiology of BD is unknown, there is substantial evidence suggesting that it is associated with genetic, epigenetic, and neurochemical factors. Heritability is well established. A child who has a biological parent with BD is at a 15-30% risk of developing the disorder, and the risk increases to 50-75% when both parents are affected. This familial risk is widely recognized and presents a compelling opportunity for preventive measures, particularly during the prodromal phase, prior to the realization of full diagnostic criteria.
Purpose:
The purpose of this research is to develop and evaluate a stakeholder-informed, scalable screening approach in a pilot feasibility study for early identification of mental health risk in youth (ages 7-21) who have a biological parent with bipolar disorder (BD). Despite well-documented genetic risk, there is currently no established protocol to support family-initiated screening in this high-risk group.
Objectives:
- Develop and refine a brief, co-designed video decision aid (DA) to support BD-affected adults or caregivers in making informed choices about screening their children.
- Evaluate the decision aid's effectiveness in improving knowledge, reducing decisional conflict, and increasing willingness to screen among caregivers.
- Conduct pilot mental health screenings of at-risk youth using a hybrid model combining fixed prodromal symptom items and the Computerized Adaptive Test for Mental Health (CAT-MH®) and Kiddie Computerized Adaptive Test for Mental Health (K-CAT-MH®) adaptive screeners.
- Create and evaluate a structured follow-up framework that stratifies screening results by risk and links them to relevant next steps in care.
Hypothesis:
The hypothesis is that a family-centered, stakeholder-designed decision aid will encourage a significant portion of BD-affected adults or caregivers to consent to their children's screening and that adaptive screening will find youth with early symptom patterns that might benefit from further monitoring or risk-stratified follow-up. The goal is not to identify all at-risk youth, but rather to assess the feasibility, acceptability, and preliminary yield of this family-informed screening model.
This hypothesis is supported by evidence that early symptoms such as mood instability, anxiety, and behavioral dysregulation often precede the onset of full syndromal BD, particularly in youth with a biological parent diagnosed with BD. However, existing early identification models are largely clinician-driven, and families often lack tools to guide screening decisions. Decision aids, which are widely used in other areas of healthcare, have been shown to improve decision quality, reduce decisional conflict, and increase knowledge - particularly in situations involving uncertainty or personal values. There is strong evidence that decision-making informed by stakeholders enhances the relevance, uptake, and ethical alignment of initiatives, particularly when engaging families on sensitive or stigmatized clinical topics. Finally, recent research has shown that remote, adaptive mental health screening is feasible in high-risk youth populations. These results collectively substantiate the rationale for the piloting of a novel, family-centered approach that integrates stakeholder-informed decision assistance with adaptive screening and structured follow-up.
Overarching Study Goal:
The long-term goal of this work is to generate a scalable, evidence-based model for early detection of psychiatric risk in youth with a familial history of BD. By fostering informed caregiver engagement and incorporating risk-stratified follow-up recommendations, this project establishes the foundation for future practice guidelines that transition the field from reactive diagnosis to preventive mental health care. This approach is comparable to those employed in other heritable conditions, such as cancer and heart disease.
- Conditions
- Bipolar Disorder (BD), Bipolar Disorder I or II, Bipolar Disorder Family Members, Screening Tool
- Being tested
- Co-design Workshop (Observational Procedure), Alpha Testing (Observational Procedure), Beta Testing (Observational Procedure), Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)
- Keywords
- bipolar disorder, bipolar I, bipolar II, bipolar disorder screening
- Medical subject headings
- Bipolar Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Co-design Workshop (Observational Procedure)Other
Participants in the workshop will help to co-design decision aid prototypes (short video and FAQ document) focused on early mental health screening for youth with one or more biological parents impacted by BD.
Alpha Testing (Observational Procedure)Other
Participants will provide feedback on the initial version of the patient decision aid (short video and FAQ document).
Beta Testing (Observational Procedure)Other
Participants will provide feedback on the refined version of the patient decision aid (short video and FAQ document).
Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)Other
Youth participants will take screening surveys for early bipolar risk detection.
| Study group | Role | What they receive |
|---|---|---|
| Group A - Parent with Bipolar Disorder | Parents (age 18 or older) who have ever been diagnosed with bipolar disorder and have a biological child between the ages of 7-21 Receives: Other: Co-design Workshop (Observational Procedure); Other: Alpha Testing (Observational Procedure); Other: Beta Testing (Observational Procedure) | |
| Group B - Adult Caregiver | Caregivers (age 18 or older) who are primarily responsible for a child between the ages of 7-21 whose biological parent has a lifetime diagnosis of bipolar disorder Receives: Other: Co-design Workshop (Observational Procedure); Other: Alpha Testing (Observational Procedure); Other: Beta Testing (Observational Procedure) | |
| Group C - At-Risk Youth | Youth (ages 7-21) without bipolar disorder, but has at least 1 biological parent with a lifetime diagnosis of bipolar disorder Receives: Other: Co-design Workshop (Observational Procedure); Other: Alpha Testing (Observational Procedure); Other: Beta Testing (Observational Procedure); Other: Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Decision Aid Acceptability Score
Mean participant rating of decision aid acceptability using study-specific Likert-type items assessing clarity, balance, trustworthiness, and usefulness. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate greater acceptability.
Measured: 16 Months
Decision Aid Usability Score
Description:
Mean participant rating of decision aid usability using study-specific Likert-type items assessing ease of navigation, visual clarity, and overall satisfaction. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate greater usability.
Measured: 16 Months
Youth Screening Uptake Rate
Percentage of eligible caregivers who consent for youth mental health screening after participation in the decision-aid workflow.
Measured: 16 Months
Youth Screening Completion Rate
Percentage of youth participants who complete the assigned remote mental health screening battery after consent or permission and assent, as applicable.
Measured: 16 Months
Secondary outcomes (4)
Time to Complete Youth Screening
Time in minutes required for youth participants to complete the assigned remote mental health screening battery.
Measured: 16 Months
Youth and Caregiver Post-Screening Feedback Score
Mean post-screening feedback score from youth and caregiver surveys assessing clarity, comfort, perceived burden, and usefulness of the screening process. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate more favorable feedback.
Measured: 16 Months
Safety Flag Rate
Percentage of screened youth whose responses trigger the study safety protocol based on pre-specified screening thresholds.
Measured: 16 Months
Risk Stratification Category Distribution
Percentage of screened youth assigned to each pre-specified risk category based on the fixed-item and adaptive screening algorithm. Categories may include low, moderate, or elevated risk.
Measured: 16 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2026
- Study start11 Mar 2026
- Primary completion30 Jun 2027 (estimated)
- Study completion31 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bipolar Disorder (BD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Family based
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- The Texas Child Mental Health Care Consortium (TCMHCC)
- Responsible party
- Principal investigator, Karabi Nandy, University of Texas Southwestern Medical Center
- Investigators
- Karabi Nandy, PhD, Principal investigator, University of Texas Southwestern Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07622927
- Sponsor's protocol ID
- STU20251974
- Acronym
- FOCUS Bipolar
- Status last verified
- May 2026
- First submitted
- 21 Feb 2026
- Last updated
- 3 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Data-Driven Approach to Early Mental Health Screening in Offspring of Parents With Bipolar Disorder
- ClinicalTrials.gov ID
- NCT07622927
- Acronym / sponsor ID
- FOCUS Bipolar / STU20251974
- Conditions
- Bipolar Disorder (BD), Bipolar Disorder I or II, Bipolar Disorder Family Members, Screening Tool
- Keywords
- bipolar disorder, bipolar I, bipolar II, bipolar disorder screening
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of Texas Southwestern Medical CenterUniversity, hospital or other
- Collaborators
- The Texas Child Mental Health Care Consortium (TCMHCC)
- Study start
- 11 Mar 2026 (actual)
- Primary completion
- 30 Jun 2027 (estimated)
- Study completion
- 31 Jul 2027 (estimated)
- First posted
- 3 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Bipolar disorder often runs in families, but early symptoms in youth can go unrecognized for years. This project evaluates a structured, family-centered approach to informed screening for youth ages 7-21 who have a biological parent with bipolar disorder.
The main questions addressed by this project are:
Whether a co-designed video decision aid improves caregiver understanding of bipolar disorder genetic risk and supports informed decisions about youth screening.
Whether remote mental health screening tools are feasible and acceptable for youth with familial risk for bipolar disorder.
Whether screening results can be used to identify early risk patterns and inform tailored follow-up recommendations.
Participants may be involved in one or more study activities, including co-design of educational decision-aid content, feedback on decision-aid prototypes, beta testing of the decision aid, and remote youth mental health screening. The study does not assign treatment and does not change existing clinical care or clinic routines.
Detailed description
Background and Rationale:
Bipolar disorder (BD), characterized by acute mood fluctuations between manic and depressive states, affects approximately 5.7 million adults each year in the United States and is the fourth leading cause of disability among those aged 10-24 worldwide. BD is estimated to inflict an annual economic burden of $195 billion in the United States alone. Despite its high prevalence and significant impact on both disability and the economy, BD is typically diagnosed 11-17 years after symptom emergence. This results in delayed intervention, increased morbidity, and an elevated suicide risk.
While the etiology of BD is unknown, there is substantial evidence suggesting that it is associated with genetic, epigenetic, and neurochemical factors. Heritability is well established. A child who has a biological parent with BD is at a 15-30% risk of developing the disorder, and the risk increases to 50-75% when both parents are affected. This familial risk is widely recognized and presents a compelling opportunity for preventive measures, particularly during the prodromal phase, prior to the realization of full diagnostic criteria.
Purpose:
The purpose of this research is to develop and evaluate a stakeholder-informed, scalable screening approach in a pilot feasibility study for early identification of mental health risk in youth (ages 7-21) who have a biological parent with bipolar disorder (BD). Despite well-documented genetic risk, there is currently no established protocol to support family-initiated screening in this high-risk group.
Objectives:
- Develop and refine a brief, co-designed video decision aid (DA) to support BD-affected adults or caregivers in making informed choices about screening their children.
- Evaluate the decision aid's effectiveness in improving knowledge, reducing decisional conflict, and increasing willingness to screen among caregivers.
- Conduct pilot mental health screenings of at-risk youth using a hybrid model combining fixed prodromal symptom items and the Computerized Adaptive Test for Mental Health (CAT-MH®) and Kiddie Computerized Adaptive Test for Mental Health (K-CAT-MH®) adaptive screeners.
- Create and evaluate a structured follow-up framework that stratifies screening results by risk and links them to relevant next steps in care.
Hypothesis:
The hypothesis is that a family-centered, stakeholder-designed decision aid will encourage a significant portion of BD-affected adults or caregivers to consent to their children's screening and that adaptive screening will find youth with early symptom patterns that might benefit from further monitoring or risk-stratified follow-up. The goal is not to identify all at-risk youth, but rather to assess the feasibility, acceptability, and preliminary yield of this family-informed screening model.
This hypothesis is supported by evidence that early symptoms such as mood instability, anxiety, and behavioral dysregulation often precede the onset of full syndromal BD, particularly in youth with a biological parent diagnosed with BD. However, existing early identification models are largely clinician-driven, and families often lack tools to guide screening decisions. Decision aids, which are widely used in other areas of healthcare, have been shown to improve decision quality, reduce decisional conflict, and increase knowledge - particularly in situations involving uncertainty or personal values. There is strong evidence that decision-making informed by stakeholders enhances the relevance, uptake, and ethical alignment of initiatives, particularly when engaging families on sensitive or stigmatized clinical topics. Finally, recent research has shown that remote, adaptive mental health screening is feasible in high-risk youth populations. These results collectively substantiate the rationale for the piloting of a novel, family-centered approach that integrates stakeholder-informed decision assistance with adaptive screening and structured follow-up.
Overarching Study Goal:
The long-term goal of this work is to generate a scalable, evidence-based model for early detection of psychiatric risk in youth with a familial history of BD. By fostering informed caregiver engagement and incorporating risk-stratified follow-up recommendations, this project establishes the foundation for future practice guidelines that transition the field from reactive diagnosis to preventive mental health care. This approach is comparable to those employed in other heritable conditions, such as cancer and heart disease.
Study design
- Observational model
- Family based
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Group A - Parent with Bipolar Disorder | – | Other: Co-design Workshop (Observational Procedure), Other: Alpha Testing (Observational Procedure), Other: Beta Testing (Observational Procedure)Parents (age 18 or older) who have ever been diagnosed with bipolar disorder and have a biological child between the ages of 7-21 |
| Group B - Adult Caregiver | – | Other: Co-design Workshop (Observational Procedure), Other: Alpha Testing (Observational Procedure), Other: Beta Testing (Observational Procedure)Caregivers (age 18 or older) who are primarily responsible for a child between the ages of 7-21 whose biological parent has a lifetime diagnosis of bipolar disorder |
| Group C - At-Risk Youth | – | Other: Co-design Workshop (Observational Procedure), Other: Alpha Testing (Observational Procedure), Other: Beta Testing (Observational Procedure), Other: Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)Youth (ages 7-21) without bipolar disorder, but has at least 1 biological parent with a lifetime diagnosis of bipolar disorder |
Who may qualify
- Ages
- 7 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The following groups are being targeted for this observational study: 1. Parents (age 18 or older) who have ever been diagnosed with bipolar disorder and have a biological child between the ages of 7-21 2. Caregivers (age 18 or older) who are primarily responsible for a child between the ages of 7-21 whose biological parent has a lifetime diagnosis of bipolar disorder 3. Youth (ages 7-21) without bipolar disorder, but has at least 1 biological parent with a lifetime diagnosis of bipolar disorder
Key inclusion criteria (21 listed)
- Age: 18 years or older.
- Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder.
- Capacity and willingness to consent: Able and willing to provide informed consent.
- Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments).
- Language: Able to read, speak, and understand English.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Co-design Workshop (Observational Procedure)Participants in the workshop will help to co-design decision aid prototypes (short video and FAQ document) focused on early mental health screening for youth with one or more biological parents impacted by BD. | Other | Group A - Parent with Bipolar Disorder, Group B - Adult Caregiver, Group C - At-Risk Youth |
| Alpha Testing (Observational Procedure)Participants will provide feedback on the initial version of the patient decision aid (short video and FAQ document). | Other | Group A - Parent with Bipolar Disorder, Group B - Adult Caregiver, Group C - At-Risk Youth |
| Beta Testing (Observational Procedure)Participants will provide feedback on the refined version of the patient decision aid (short video and FAQ document). | Other | Group A - Parent with Bipolar Disorder, Group B - Adult Caregiver, Group C - At-Risk Youth |
| Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure)Youth participants will take screening surveys for early bipolar risk detection. | Other | Group C - At-Risk Youth |
Primary outcome
Decision Aid Acceptability Score
Time frame: 16 Months
Mean participant rating of decision aid acceptability using study-specific Likert-type items assessing clarity, balance, trustworthiness, and usefulness. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate greater acceptability.
Decision Aid Usability Score
Time frame: 16 Months
Description: Mean participant rating of decision aid usability using study-specific Likert-type items assessing ease of navigation, visual clarity, and overall satisfaction. Items are rated from 1 to 5, with 1 indicating strongly disagree and 5 indicating strongly agree. Higher scores indicate greater usability.
Youth Screening Uptake Rate
Time frame: 16 Months
Percentage of eligible caregivers who consent for youth mental health screening after participation in the decision-aid workflow.
Youth Screening Completion Rate
Time frame: 16 Months
Percentage of youth participants who complete the assigned remote mental health screening battery after consent or permission and assent, as applicable.
4 secondary outcomes
Time to Complete Youth Screening
Time frame: 16 Months
Youth and Caregiver Post-Screening Feedback Score
Time frame: 16 Months
Safety Flag Rate
Time frame: 16 Months
Risk Stratification Category Distribution
Time frame: 16 Months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Bipolar Disorder (BD)
Enrolling by invitation
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Schizophrenia Disorder, Schizoaffective Disorder
RecruitingPhase 3
Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression
Bipolar Disorder (BD)
Not yet recruiting
Evaluating the PolarUs App in People With Bipolar Disorder
Bipolar Disorder (BD), Quality of Life (QOL)
Recruiting
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP)
Not yet recruitingObservational study
BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder
Bipolar Disorder (BD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Karabi Nandy, PhD principal investigator
University of Texas Southwestern Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bipolar Disorder (BD) and Bipolar Disorder I or II, run by University of Texas Southwestern Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 21 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Karabi Nandy, Ph.D. (214-648-4490, FOCUSBipolar@UTSouthwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Decision Aid Acceptability Score (time frame: 16 Months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026; AzTrials last refreshed its copy on 26 Oct 2026.